Andrew Drechsler
Director/Board Member chez BAUDAX BIO, INC.
Fortune : 14 $ au 31/03/2024
Profil
Andrew T.
Drechsler is an Independent Director at Baudax Bio, Inc. He previously worked as a Controller at Abbott Laboratories, i-STAT Corp., and Biomatrix, Inc. He was also the Chief Financial Officer at Insmed, Inc., Valera Pharmaceuticals, Inc., VaxInnate Corp., and Provention Bio, Inc. Additionally, he worked as a Principal at Coopers & Lybrand LLP.
Drechsler received his undergraduate degree from Villanova University in 1994.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BAUDAX BIO INC
0,00% | 07/09/2023 | 1 040 ( 0,00% ) | 14 $ | 31/03/2024 |
Postes actifs de Andrew Drechsler
| Sociétés | Poste | Début |
|---|---|---|
| BAUDAX BIO, INC. | Director/Board Member | 20/08/2020 |
Anciens postes connus de Andrew Drechsler
| Sociétés | Poste | Fin |
|---|---|---|
| PROVENTION BIO, INC. | Director of Finance/CFO | 01/12/2021 |
| INSMED INCORPORATED | Director of Finance/CFO | 01/03/2017 |
VaxInnate Corp.
 VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Director of Finance/CFO | 01/11/2012 |
Valera Pharmaceuticals, Inc.
 Valera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Valera Pharmaceuticals, Inc. develops and commercializes products for the treatment of urology and endocrine conditions, diseases and disorders. The Company was founded in 1972 and is located in Cranbury, NJ. | Director of Finance/CFO | 18/04/2007 |
i-STAT Corp.
 i-STAT Corp. Medical SpecialtiesHealth Technology i-STAT Corp. is used to develope, manufacture and market medical diagnostic products for blood analysis that provide healthcare professionals critical diagnostic information accurately and immediately at the point of patient care. Founded in 1983 by Imants Lauks, i-STAT was headquartered in East Windsor, NJ. | Comptroller/Controller/Auditor | 01/01/2005 |
Formation de Andrew Drechsler
| Villanova University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| INSMED INCORPORATED | Health Technology |
| BAUDAX BIO, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
i-STAT Corp.
i-STAT Corp. Medical SpecialtiesHealth Technology i-STAT Corp. is used to develope, manufacture and market medical diagnostic products for blood analysis that provide healthcare professionals critical diagnostic information accurately and immediately at the point of patient care. Founded in 1983 by Imants Lauks, i-STAT was headquartered in East Windsor, NJ. | Health Technology |
Biomatrix, Inc.
 Biomatrix, Inc. Pharmaceuticals: MajorHealth Technology Biomatrix, Inc. develops, manufactures, markets and sells a series of proprietary viscoelastic products called 'hylans'. Hylans are the second generation of viscoelastics used in medicine and are characterized by significantly enhanced physical properties such as elasticity, viscosity and pseudoplasticity. These products are used in therapeutic medical applications and skin care. The company was founded by Endre A. Balazs and Janet L. Denlinger in 1981 and is headquartered in Ridgefield, NJ. | Health Technology |
Valera Pharmaceuticals, Inc.
Valera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Valera Pharmaceuticals, Inc. develops and commercializes products for the treatment of urology and endocrine conditions, diseases and disorders. The Company was founded in 1972 and is located in Cranbury, NJ. | Health Technology |
| Coopers & Lybrand LLP | Commercial Services |
VaxInnate Corp.
VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Health Technology |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D), PRV-015 for the treatment of gluten-free diet non-responding celiac disease, PRV-6527 for Crohn’s disease, PRV-3279 for the treatment of lupus, and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of type 1 diabetes (T1D) onset. The company was founded by Francisco Leon and Ashleigh Palmer on October 4, 2016 and is headquartered in Red Bank, NJ. | Health Technology |
